|1.||Abdool Karim, Salim S: 14 articles (11/2015 - 09/2010)|
|2.||De Clercq, Erik: 13 articles (11/2013 - 10/2003)|
|3.||Oka, Shinichi: 12 articles (06/2015 - 01/2011)|
|4.||Abdool Karim, Quarraisha: 11 articles (11/2015 - 09/2010)|
|5.||Van Rompay, Koen K A: 11 articles (01/2012 - 11/2002)|
|6.||Girard, Pierre-Marie: 10 articles (11/2015 - 12/2002)|
|7.||Baxter, Cheryl: 10 articles (08/2015 - 09/2010)|
|8.||Gatanaga, Hiroyuki: 10 articles (12/2014 - 01/2011)|
|9.||Bischofberger, Norbert: 10 articles (09/2008 - 11/2002)|
|10.||Sax, Paul E: 9 articles (06/2015 - 03/2009)|
01/01/2010 - "Tenofovir was effective against HIV-1 infection in our algorithm. "
12/01/2005 - "Tenofovir is effective in treating HBV infection in HIV patients. "
04/28/2003 - "Tenofovir effective in all stages of the infection]."
02/09/2013 - "In patients with chronic HBV infection, up to 5 years of treatment with tenofovir DF was safe and effective. "
09/01/2014 - "To evaluate the safety and efficacy of the novel tenofovir prodrug, tenofovir alafenamide (TAF), as part of a single-tablet regimen (STR) for the initial treatment of HIV-1 infection. "
|2.||Chronic Hepatitis B
06/01/2015 - "In conclusion, the tenofovir rescue regimen can be employed confidently as a highly effective and safe treatment choice following a suboptimal response to ETV plus ADV therapy for a subset of chronic hepatitis B patients with a history of multiple unsuccessful antiviral treatments."
12/01/2012 - "This study evaluated the safety and efficacy of tenofovir DF in adolescents with chronic hepatitis B (CHB). "
06/01/2015 - "Efficacy of tenofovir switch therapy for nucleos(t)ide-experienced patients with chronic hepatitis B."
01/01/2015 - "[Efficacy of tenofovir-based rescue therapy for patients with drug-resistant chronic hepatitis B]."
09/01/2013 - "Safety of coitally administered tenofovir 1% gel, a vaginal microbicide, in chronic hepatitis B virus carriers: results from the CAPRISA 004 trial."
|3.||HIV Infections (HIV Infection)
03/01/2012 - "Topical tenofovir gel has proven effective in the prevention of HIV infection in women in South Africa. "
07/01/2013 - "Tenofovir (TFV) is a widely used and effective treatment for HIV infection. "
01/01/2012 - "Tenofovir is widely used as first-line treatment of HIV infection, although its use is sometimes complicated by a reversible proximal renal tubulopathy.We"
07/01/2015 - "Genital Tenofovir Concentrations Correlate With Protection Against HIV Infection in the CAPRISA 004 Trial: Importance of Adherence for Microbicide Effectiveness."
04/24/2015 - "In this HIV PrEP trial among people who inject drugs, improved adherence to daily tenofovir was associated with a lower risk of HIV infection. "
07/01/2015 - "First report of successful clearance of hepatitis B and D coinfection with tenofovir monotherapy."
01/01/2009 - "New approaches in the management of chronic hepatitis B: role of tenofovir."
12/01/2015 - "Tenofovir, an agent used in HIV and hepatitis B therapy, may also have a role in the prevention of HSV-2 acquisition and reduce viral shedding. "
03/01/2015 - "Tenofovir alafenamide 25 mg has been selected for further hepatitis B clinical development."
05/01/2014 - "Factors associated with delayed hepatitis B viral suppression on tenofovir among patients coinfected with HBV-HIV in the CNICS cohort."
01/01/2007 - "The safety and efficacy of tenofovir in HIV/HBV cirrhosis has not been previously described. "
02/01/2015 - "One patient with compensated cirrhosis needed to change from tenofovir because of renal safety. "
11/01/2013 - "We aimed to evaluate the usefulness of various prognostic indicators in predicting the 24-months survival in HBV related decompensated cirrhosis after tenofovir therapy and to evaluate the post-treatment outcome. "
11/01/2013 - "Predictors of survival in hepatitis B virus related decompensated cirrhosis on tenofovir therapy: an Indian perspective."
09/01/2013 - "Virological response was better in patients using tenofovir (Odd's ratio of 1.796 and p = 0.014) and having high fibrosis score (Odd's ratio of 0.182 and p = 0.018). "
|5.||pinacolyl methylphosphonic acid
|7.||Hepatitis B e Antigens
|8.||RNA-Directed DNA Polymerase (Reverse Transcriptase)
|2.||Highly Active Antiretroviral Therapy (HAART)
|4.||Contraception (Birth Control)
|5.||Transplantation (Transplant Recipients)